Canada Pension Plan Investment Board
ANIK icon

Canada Pension Plan Investment Board’s Anika Therapeutics ANIK Stock Holding History

Canada Pension Plan Investment Board’s Portfolio ANIK Stock Details ANIK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$322K Hold
22,000
– – ﹤0.01% 1425
2026
Q1 		$319K Hold
22,000
– – ﹤0.01% 1401
2025
Q4 		$211K Buy
+22,000
New +$211K ﹤0.01% 1642

Other funds holding ANIK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
CM
Capital Management Glen Allen, Virginia $666M AUM 17.17% 1-Year Est. Return

Canada Pension Plan Investment Board's ANIK Position: Q2 2026 in Review

Canada Pension Plan Investment Board held its Anika Therapeutics (ANIK) position steady in Q2 2026 at 22,000 shares worth $322K. The position accounts for ﹤0.01% of the portfolio, ranked #1425.

Canada Pension Plan Investment Board first reported a position in ANIK in Q4 2025 and has held it in 3 quarters since. 133 funds tracked by Wall St. Rank hold ANIK as of Q2 2026.

  • Canada Pension Plan Investment Board held 22,000 shares of Anika Therapeutics worth $322K as of Q2 2026.
  • Canada Pension Plan Investment Board left its Anika Therapeutics share count unchanged in Q2 2026.
  • Anika Therapeutics made up ﹤0.01% of Canada Pension Plan Investment Board's portfolio in Q2 2026, its #1425 holding.
  • Canada Pension Plan Investment Board first reported a position in Anika Therapeutics in Q4 2025 and has held it in 3 quarters since.
  • 133 funds tracked by Wall St. Rank held Anika Therapeutics as of Q2 2026.

Based on Canada Pension Plan Investment Board's 13F filing for Q2 2026, filed 14 Aug 2026.